Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Yoshitomi reports potent and selective tryptase inhibitors with oral activity

May 24, 1999

Ipratropium bromide may improve sleep, nocturnal oxygen in COPD patients

May 24, 1999

Different crystalline forms of cipamfylline studied at SB

May 21, 1999

Merck discloses potent, selective and orally active PDE4 inhibitors

May 21, 1999

Positive findings from phase III trial of anti-IgE for allergic rhinitis

May 19, 1999

Inflazyme signs collaborative agreement with HMR for asthma and allergy therapeutics

May 19, 1999

Johnson & Johnson withdraws from norastemizole collaboration

May 18, 1999

SmithKline Beecham describes new series of CCR5 receptor modulators

May 17, 1999

PathoGenesis launches TOBI in second market

May 13, 1999

Asahi Glass describes dual NK1/NK2 antagonists

May 12, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...